Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00885781Phase 4Completed
Phase 4, randomised trial of SMOFlipid in Malnutrition (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Evidence for immunoregulatory effect of lipid emulsion products. Started Nov 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00885781.